- Home
- CUB vs DCTH Comparison
CUB vs DCTH Comparison
Compare CUB & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUB
- DCTH
- Stock Information
- Founded
- CUB 2024
- DCTH 1988
- Country
- CUB United States
- DCTH United States
- Employees
- CUB N/A
- DCTH N/A
- Industry
- CUB
- DCTH Medical/Dental Instruments
- Sector
- CUB
- DCTH Health Care
- Exchange
- CUB NYSE
- DCTH Nasdaq
- Market Cap
- CUB 307.3M
- DCTH 305.2M
- IPO Year
- CUB 2024
- DCTH N/A
- Fundamental
- Price
- CUB $10.03
- DCTH $10.94
- Analyst Decision
- CUB
- DCTH Strong Buy
- Analyst Count
- CUB 0
- DCTH 4
- Target Price
- CUB N/A
- DCTH $21.50
- AVG Volume (30 Days)
- CUB 33.4K
- DCTH 363.4K
- Earning Date
- CUB 01-01-0001
- DCTH 11-08-2024
- Dividend Yield
- CUB N/A
- DCTH N/A
- EPS Growth
- CUB N/A
- DCTH N/A
- EPS
- CUB N/A
- DCTH N/A
- Revenue
- CUB N/A
- DCTH $11,878,000.00
- Revenue This Year
- CUB N/A
- DCTH $1,562.76
- Revenue Next Year
- CUB N/A
- DCTH $117.72
- P/E Ratio
- CUB N/A
- DCTH N/A
- Revenue Growth
- CUB N/A
- DCTH 350.44
- 52 Week Low
- CUB $9.96
- DCTH $2.25
- 52 Week High
- CUB $10.49
- DCTH $11.75
- Technical
- Relative Strength Index (RSI)
- CUB N/A
- DCTH 61.81
- Support Level
- CUB N/A
- DCTH $10.11
- Resistance Level
- CUB N/A
- DCTH $11.24
- Average True Range (ATR)
- CUB 0.00
- DCTH 0.54
- MACD
- CUB 0.00
- DCTH 0.00
- Stochastic Oscillator
- CUB 0.00
- DCTH 53.55
About CUB LIONHEART HOLDINGS
Lionheart Holdings is a blank check company.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.